The mission of our clinical research is to foster discoveries in the novel therapies of inflammatory bowel diseases, gastrointestinal and pancreatic cancer, hepatitis, and other gastrointestinal disorders. Our doctors are committed to providing the best care and management of diseases while testing cutting-edge therapies.

Back to full list of clinical trials

Ongoing clinical trials for primary sclerosing cholangitis: Actively recruiting


Primary Sclerosing Cholangitis

Study title:

Primary Sclerosing Cholangitis Registry at MGH

Description of study:

This study includes any patients with PSC. It allows for 2-4 extra tubes of blood to be drawn during routine clinical draws, excess bile at the time of ERCP and for excess liver tissue if available after biopsy.

Basic eligibility criteria:

Adults diagnosed with PSC

Principal Investigator:

Dan Pratt, MD


Robin Ly; 617-643-7480